글로벌 임상 시험 영상 시장 (2024-2030) : 임상 시험 설계 및 컨설팅 서비스, 판곳 및 분석 서비스

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product
1.1.2. End-use
1.1.3. Regional scope
1.1.4. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for Primary Interviews in North America
1.3.5.2. Data for primary interviews in Europe
1.3.5.3. Data for primary interviews in Asia Pacific
1.3.5.4. Data for Primary Interviews in Latin America
1.3.5.5. Data for Primary Interviews in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. End-use outlook
2.2.3. Regional outlook
2.3. Competitive Insights
Chapter 3. Clinical Trial Imaging Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.3.1. Reimbursement framework
3.4. Market Dynamics
3.4.1. Market Driver Analysis
3.4.1.1. Growing number of pharmaceutical and biotechnological companies
3.4.1.2. Growing number of contract research organizations (CRO)
3.4.1.3. Increasing research and development investments
3.4.2. Market Restraint Analysis
3.4.2.1. High cost of machinery and installations
3.5. X-ray Systems Market Analysis Tools
3.5.1. Industry Analysis – Porter’s
3.5.1.1. Supplier power
3.5.1.2. Buyer power
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
3.5.2.1. Political landscape
3.5.2.2. Technological landscape
3.5.2.3. Economic Landscape
3.5.3. Major Deals & Strategic Alliances Analysis
3.5.4. Market Entry Strategies
Chapter 4. Clinical Trial Imaging Market: Service Estimates & Trend Analysis
4.1. Definitions and Scope
4.1.1. Clinical Trial Design and Consultation Services
4.1.2. Reading and Analytical Services
4.1.3. Operational Imaging
4.1.3.1. Computed Tomography (CT) Scan
4.1.3.2. MRI (Magnetic Resonance Imaging)
4.1.3.3. X-ray
4.1.3.4. Ultrasound
4.1.3.5. Optical Coherence Tomography (OCT)
4.1.3.6. Others
4.1.4. System and Technology Support Services
4.1.5. Project and Data Management
4.2. Services Market Share, 2018 & 2030
4.3. Segment Dashboard
4.4. Global Clinical Trial Imaging Market by Product Outlook
4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5.1. Clinical Trial Design and Consultation Services
4.5.1.1. Clinical Trial Design and Consultation Services market estimates and forecast 2018 to 2030 (USD Million)
4.5.2. Reading and Analytical Services
4.5.2.1. Reading and Analytical Services market estimates and forecast 2018 to 2030 (USD Million)
4.5.3. Operational Imaging Services
4.5.3.1. Operational Imaging Services market estimates and forecast 2018 to 2030 (USD Million)
4.5.3.2. Computed Tomography (CT) Scan
4.5.3.2.1. Computed Tomography (CT) Scan market estimates and forecast 2018 to 2030 (USD Million)
4.5.3.3. Magnetic Resonance Imaging (MRI)
4.5.3.3.1. Magnetic Resonance Imaging (MRI) Scan market estimates and forecast 2018 to 2030 (USD Million)
4.5.3.4. X-rays
4.5.3.4.1. X-rays Scan market estimates and forecast 2018 to 2030 (USD Million)
4.5.3.5. Ultrasound
4.5.3.5.1. Ultrasound market estimates and forecast 2018 to 2030 (USD Million)
4.5.3.6. Optical Coherence Tomography (OCT)
4.5.3.6.1. Optical Coherence Tomography (OCT) market estimates and forecast 2018 to 2030 (USD Million)
4.5.3.7. Others
4.5.3.7.1. Others market estimates and forecast 2018 to 2030 (USD Million)
4.5.4. System and Technology Support Services
4.5.4.1. System and Technology Support Services market estimates and forecast 2018 to 2030 (USD Million)
4.5.5. Project and Data Management
4.5.5.1. Project and Data Management market estimates and forecast 2018 to 2030 (USD Million)
Chapter 5. Clinical Trial Imaging Market: Application Estimates & Trend Analysis
5.1. Definitions and Scope
5.1.1. Nonalcoholic Steatohepatitis (NASH)
5.1.2. Chronic Kidney Disease (CKD)
5.1.3. Diabetes
5.1.4. Cardiovascular Diseases
5.1.5. Ophthalmology
5.1.6. Musculoskeletal
5.1.7. Oncology
5.1.8. Gastroenterology
5.1.9. Pediatrics
5.1.10. Others
5.2. Application Market Share, 2018 & 2030
5.3. Segment Dashboard
5.4. Clinical Trial Imaging Market by Application Outlook
5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5.1. Nonalcoholic Steatohepatitis (NASH)
5.5.1.1. Nonalcoholic steatohepatitis estimates and forecast 2018 to 2030 (USD Million)
5.5.2. Chronic Kidney Disease
5.5.2.1. Chronic kidney disease estimates and forecast 2018 to 2030 (USD Million)
5.5.3. Diabetes
5.5.3.1. Diabetes market estimates and forecast 2018 to 2030 (USD Million)
5.5.4. Cardiovascular Diseases
5.5.4.1. Cardiovascular diseases market estimates and forecast 2018 to 2030 (USD Million)
5.5.5. Ophthalmology
5.5.5.1. Ophthalmology market estimates and forecast 2018 to 2030 (USD Million)
5.5.6. Oncology
5.5.6.1. Oncology market estimates and forecast 2018 to 2030 (USD Million)
5.5.7. Musculoskeletal
5.5.7.1. Musculoskeletal market estimates and forecast 2018 to 2030 (USD Million)
5.5.8. Gastroenterology
5.5.8.1. Gastroenterology market estimates and forecast 2018 to 2030 (USD Million)
5.5.9. Pediatrics
5.5.9.1. Pediatrics market estimates and forecast 2018 to 2030 (USD Million)
5.5.10. Others
5.5.10.1. Others market estimates and forecast 2018 to 2030 (USD Million)
Chapter 6. Clinical Trial Imaging Market: End-use Estimates & Trend Analysis
6.1. Definitions and Scope
6.1.1. Biotechnology and Pharmaceutical Companies
6.1.2. Medical Devices Manufacturers
6.1.3. Academic and Government Research Institutes
6.1.4. Contract Research Organization (CRO)
6.1.5. Others (Cosmetics and skin care industries)
6.2. End-use Market Share, 2018 & 2030
6.3. Segment Dashboard
6.4. Clinical Trial Imaging Market by End-use Outlook
6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.5.1. Biotechnology and Pharmaceutical Companies
6.5.1.1. Biotechnology and pharmaceutical companies estimates and forecast 2018 to 2030 (USD Million)
6.5.2. Medical Devices Manufacturers
6.5.2.1. Medical devices manufacturers estimates and forecast 2018 to 2030 (USD Million)
6.5.3. Academic and Government Research Institutes
6.5.3.1. Academic and government research institutes market estimates and forecast 2018 to 2030 (USD Million)
6.5.4. Contract Research Organization (CRO)
6.5.4.1. Contract research organization (CRO) market estimates and forecast 2018 to 2030 (USD Million)
6.5.5. Others
6.5.5.1. Others market estimates and forecast 2018 to 2030 (USD Million)
Chapter 7. Clinical Trial Imaging Market: Regional Estimates & Trend Analysis
7.1. Regional market share analysis, 2018 & 2030
7.2. Regional Market Dashboard
7.3. Global Regional Market Snapshot
7.4. Regional Market Share and Leading Players, 2022
7.4.1. North America
7.4.2. Europe
7.4.3. Asia Pacific
7.4.4. Latin America
7.4.5. Middle East and Africa
7.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
7.5.1. North America
7.5.2. Europe
7.5.3. Asia Pacific
7.5.4. Latin America
7.5.5. Middle East and Africa
7.6. Market Size, & Forecasts, Volume and Trend Analysis, 2018 to 2030:
7.7. North America
7.7.1. North America Clinical Trial Imaging Market Estimates and Forecasts, 2018 – 2030 (USD Million)
7.7.2. U.S.
7.7.2.1. Key Country Dynamics
7.7.2.2. Competitive Scenario
7.7.2.3. Regulatory Framework
7.7.2.4. U.S. Clinical Trial Imaging Market Estimates and Forecasts, 2018 – 2030 (USD Million)
7.7.3. Canada
7.7.3.1. Key Country Dynamics
7.7.3.2. Competitive Scenario
7.7.3.3. Regulatory Framework
7.7.3.4. Canada Clinical Trial Imaging Market Estimates and Forecasts, 2018 – 2030 (USD Million)
7.8. Europe
7.8.1. Europe Clinical Trial Imaging Market Estimates and Forecasts, 2018 – 2030 (USD Million)
7.8.2. UK
7.8.2.1. Key Country Dynamics
7.8.2.2. Competitive Scenario
7.8.2.3. Regulatory Framework
7.8.2.4. UK Clinical Trial Imaging Market Estimates and Forecasts, 2018 – 2030 (USD Million)
7.8.3. Germany
7.8.3.1. Key Country Dynamics
7.8.3.2. Competitive Scenario
7.8.3.3. Regulatory Framework
7.8.3.4. Germany Clinical Trial Imaging Market Estimates and Forecasts, 2018 – 2030 (USD Million)
7.8.4. France
7.8.4.1. Key Country Dynamics
7.8.4.2. Competitive Scenario
7.8.4.3. Regulatory Framework
7.8.4.4. France Clinical Trial Imaging Market Estimates and Forecasts, 2018 – 2030 (USD Million)
7.8.5. Italy
7.8.5.1. Key Country Dynamics
7.8.5.2. Competitive Scenario
7.8.5.3. Regulatory Framework
7.8.5.4. Italy Clinical Trial Imaging Market Estimates and Forecasts, 2018 – 2030 (USD Million)
7.8.6. Spain
7.8.6.1. Key Country Dynamics
7.8.6.2. Competitive Scenario
7.8.6.3. Regulatory Framework
7.8.6.4. Spain Clinical Trial Imaging Market Estimates and Forecasts, 2018 – 2030 (USD Million)
7.8.7. Denmark
7.8.7.1. Key Country Dynamics
7.8.7.2. Competitive Scenario
7.8.7.3. Regulatory Framework
7.8.7.4. Denmark Clinical Trial Imaging Market Estimates and Forecasts, 2018 – 2030 (USD Million)
7.8.8. Sweden
7.8.8.1. Key Country Dynamics
7.8.8.2. Competitive Scenario
7.8.8.3. Regulatory Framework
7.8.8.4. Sweden Clinical Trial Imaging Market Estimates and Forecasts, 2018 – 2030 (USD Million)
7.8.9. Norway
7.8.9.1. Key Country Dynamics
7.8.9.2. Competitive Scenario
7.8.9.3. Regulatory Framework
7.8.9.4. Norway Clinical Trial Imaging Market Estimates and Forecasts, 2018 – 2030 (USD Million)
7.9. Asia Pacific
7.9.1. Asia Pacific Clinical Trial Imaging Market Estimates and Forecasts, 2018 – 2030 (USD Million)
7.9.2. Japan
7.9.2.1. Key Country Dynamics
7.9.2.2. Competitive Scenario
7.9.2.3. Regulatory Framework
7.9.2.4. Japan Clinical Trial Imaging Market Estimates and Forecasts, 2018 – 2030 (USD Million)
7.9.3. China
7.9.3.1. Key Country Dynamics
7.9.3.2. Competitive Scenario
7.9.3.3. Regulatory Framework
7.9.3.4. China Clinical Trial Imaging Market Estimates and Forecasts, 2018 – 2030 (USD Million)
7.9.4. India
7.9.4.1. Key Country Dynamics
7.9.4.2. Competitive Scenario
7.9.4.3. Regulatory Framework
7.9.4.4. India Clinical Trial Imaging Market Estimates and Forecasts, 2018 – 2030 (USD Million)
7.9.5. South Korea
7.9.5.1. Key Country Dynamics
7.9.5.2. Competitive Scenario
7.9.5.3. Regulatory Framework
7.9.5.4. South Korea Clinical Trial Imaging Market Estimates and Forecasts, 2018 – 2030 (USD Million)
7.9.6. Australia
7.9.6.1. Key Country Dynamics
7.9.6.2. Competitive Scenario
7.9.6.3. Regulatory Framework
7.9.6.4. Australia Clinical Trial Imaging Market Estimates and Forecasts, 2018 – 2030 (USD Million)
7.9.7. Thailand
7.9.7.1. Key Country Dynamics
7.9.7.2. Competitive Scenario
7.9.7.3. Regulatory Framework
7.9.7.4. Thailand Clinical Trial Imaging Market Estimates and Forecasts, 2018 – 2030 (USD Million)
7.10. Latin America
7.10.1. Latin America Clinical Trial Imaging Market Estimates and Forecasts, 2018 – 2030 (USD Million)
7.10.2. Brazil
7.10.2.1. Key Country Dynamics
7.10.2.2. Competitive Scenario
7.10.2.3. Regulatory Framework
7.10.2.4. Brazil Clinical Trial Imaging Market Estimates and Forecasts, 2018 – 2030 (USD Million)
7.10.3. Mexico
7.10.3.1. Key Country Dynamics
7.10.3.2. Competitive Scenario
7.10.3.3. Regulatory Framework
7.10.3.4. Mexico Clinical Trial Imaging Market Estimates and Forecasts, 2018 – 2030 (USD Million)
7.10.4. Argentina
7.10.4.1. Key Country Dynamics
7.10.4.2. Competitive Scenario
7.10.4.3. Regulatory Framework
7.10.4.4. Argentina Clinical Trial Imaging Market Estimates and Forecasts, 2018 – 2030 (USD Million)
7.11. Middle East & Africa
7.11.1. Middle East & Africa Clinical Trial Imaging Market Estimates and Forecasts, 2018 – 2030 (USD Million)
7.11.2. South Africa
7.11.2.1. Key Country Dynamics
7.11.2.2. Competitive Scenario
7.11.2.3. Regulatory Framework
7.11.2.4. South Africa Clinical Trial Imaging Market Estimates and Forecasts, 2018 – 2030 (USD Million)
7.11.3. Saudi Arabia
7.11.3.1. Key Country Dynamics
7.11.3.2. Competitive Scenario
7.11.3.3. Regulatory Framework
7.11.3.4. Saudi Arabia Clinical Trial Imaging Market Estimates and Forecasts, 2018 – 2030 (USD Million)
7.11.4. UAE
7.11.4.1. Key Country Dynamics
7.11.4.2. Competitive Scenario
7.11.4.3. Regulatory Framework
7.11.4.4. UAE Clinical Trial Imaging Market Estimates and Forecasts, 2018 – 2030 (USD Million)
7.11.5. Kuwait
7.11.5.1. Key Country Dynamics
7.11.5.2. Competitive Scenario
7.11.5.3. Regulatory Framework
7.11.5.4. Kuwait Clinical Trial Imaging Market Estimates and Forecasts, 2018 – 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.2.1. Innovators
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Key Company Market Share Analysis, 2022
8.3.4. IXICO plc
8.3.4.1. Company overview
8.3.4.2. Financial performance
8.3.4.3. Modality benchmarking
8.3.4.4. Strategic initiatives
8.3.5. Navitas Life Sciences
8.3.5.1. Company overview
8.3.5.2. Financial performance
8.3.5.3. Modality benchmarking
8.3.5.4. Strategic initiatives
8.3.6. Resonance Health
8.3.6.1. Company overview
8.3.6.2. Financial performance
8.3.6.3. Modality benchmarking
8.3.6.4. Strategic initiatives
8.3.7. ProScan Imaging
8.3.7.1. Company overview
8.3.7.2. Financial performance
8.3.7.3. Modality benchmarking
8.3.7.4. Strategic initiatives
8.3.8. Radiant Sage LLC
8.3.8.1. Company overview
8.3.8.2. Financial performance
8.3.8.3. Modality benchmarking
8.3.8.4. Strategic initiatives
8.3.9. Medpace
8.3.9.1. Company overview
8.3.9.2. Financial performance
8.3.9.3. Modality benchmarking
8.3.9.4. Strategic initiatives
8.3.10. Biomedical Systems Corp.
8.3.10.1. Company overview
8.3.10.2. Financial performance
8.3.10.3. Modality benchmarking
8.3.10.4. Strategic initiatives
8.3.11. Cardiovascular Imaging Technologies
8.3.11.1. Company overview
8.3.11.2. Financial performance
8.3.11.3. Modality benchmarking
8.3.11.4. Strategic initiatives
8.3.12. Intrinsic Imaging
8.3.12.1. Company overview
8.3.12.2. Financial performance
8.3.12.3. Modality benchmarking
8.3.12.4. Strategic initiatives
8.3.13. BioTelemetry
8.3.13.1. Company overview
8.3.13.2. Financial performance
8.3.13.3. Modality benchmarking
8.3.13.4. Strategic initiatives